首页 > 市场调查报告书 > 製药

精神疾病

市场调查报告书

商品编码

1441228

全球睡眠障碍市场规模、份额、成长分析（按睡眠障碍类型、诊断方法）- 2023-2030 年产业预测

Global Sleep Disorder Market Size, Share, Growth Analysis, By Type of Sleep Disorder(Insomnia, Sleep Apnea), By Diagnosis Method(Polysomnography (PSG), Actigraphy) - Industry Forecast 2023-2030

出版日期: 2024年02月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球睡眠障碍市场规模将达到225亿美元，预测期内（2024-2031年）复合年增长率为12%，从2023年的26.1亿美元增加到2031年的153.2亿美元。预计将增长到美国10,000,000 美元。

全球睡眠障碍市场涉及影响睡眠品质和持续时间的各种睡眠相关疾病的诊断、治疗和管理。随着人们越来越认识到睡眠对整体健康和福祉的重要性，这个市场正在获得巨大的吸引力。睡眠障碍包括多种病症，包括失眠、睡眠呼吸中止症、不宁腿症候群和发作性睡病。有几个因素推动市场。随着生活方式的改变、压力水平的上升以及睡眠相关疾病的流行，人们对睡眠障碍的认识不断提高，对诊断和治疗的需求激增。科技进步带来了创新的诊断工具和治疗方案，例如穿戴式装置和远端医疗解决方案，促进了市场成长。此外，越来越多的老年人口容易出现睡眠障碍，以及肥胖和糖尿病等慢性病的盛行率不断上升，这些疾病可能会加剧睡眠问题，这进一步推动了对有效干预措施的需求。因此，製药公司、医疗设备製造商和医疗保健提供者正在投资研发，以提供改进的睡眠障碍治疗方法和解决方案。由于人们更深入了解睡眠对整体健康的影响，并努力满足面临睡眠相关挑战的个人的多样化需求，预计睡眠障碍市场将继续呈上升趋势。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争形势

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

ResMed Inc.
Philips Healthcare
Fisher & Paykel Healthcare
Inspire Medical Systems
Sleep Number Corporation
Koninklijke Philips NV.
Natus Medical Incorporated
Compumedics Limited
Becton, Dickinson and Company
Itamar Medical Ltd.
Nihon Kohden Corporation
Medtronic plc
DeVilbiss Healthcare
Drive DeVilbiss Healthcare
Cardinal Health
NovaSom, Inc.
Advanced Brain Monitoring
SleepMed Inc.
Sefam
BMC Medical Co., Ltd.

简介目录

Product Code: SQMIG35D2156

Global Sleep Disorder Market size was valued at USD 22.50 Billion in 2022 and is poised to grow from USD 2.61 Billion in 2023 to USD 15.32 Billion by 2031, at a CAGR of 12% during the forecast period (2024-2031).

The Global Sleep Disorder Market pertains to the diagnosis, treatment, and management of various sleep-related conditions that affect the quality and duration of sleep. With the increasing recognition of the importance of sleep for overall health and well-being, this market has garnered significant attention. Sleep disorders encompass a range of conditions, including insomnia, sleep apnea, restless legs syndrome, narcolepsy, and more. Several factors drive the market. The rising awareness of sleep disorders, along with changing lifestyles, increased stress levels, and the prevalence of sleep-related medical conditions, has spurred demand for diagnosis and treatment. Technological advancements have resulted in innovative diagnostic tools and treatment options, such as wearable devices and telemedicine solutions, contributing to market growth. Moreover, the expanding geriatric population, more susceptible to sleep disorders, and the increasing prevalence of obesity and chronic conditions like diabetes, which can exacerbate sleep issues, further fuel the demand for effective interventions. Consequently, pharmaceutical companies, medical device manufacturers, and healthcare providers are investing in research and development to offer improved therapies and solutions for sleep disorders. The sleep disorder market is expected to maintain its upward trajectory due to the growing understanding of the impact of sleep on overall health and ongoing efforts to address the diverse needs of individuals facing sleep-related challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sleep Disorder Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Sleep Disorder Market Segmental Analysis

The global sleep disorder market is segmented by Type of Sleep Disorder, Diagnosis Method, End-use and Region. Based on Type of sleep disorder the market is Insomnia, Sleep Apnea, Restless Legs Syndrome (RLS), Narcolepsy, Parasomnias (sleepwalking, night terrors, etc.), and Circadian Rhythm Disorders. Based on Diagnosis Method the market is segmented as, Polysomnography (PSG), Actigraphy, Home Sleep Apnea Test (HSAT), Multiple Sleep Latency Test (MSLT), Electroencephalography (EEG), Others. Based on End-User the segments are segmented as Hospitals and Clinics, Sleep Centers, Homecare Settings, Diagnostic Laboratories. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA)

Drivers of the Global Sleep Disorder Market

The increasing awareness of the adverse health consequences associated with sleep disorders serves as a significant driver. Greater education and information dissemination through various channels are encouraging individuals to proactively seek diagnosis and treatment for their sleep-related concerns.

Ongoing advancements in diagnostic tools and treatment options, including the development of portable sleep monitoring devices and telemedicine solutions, contribute to market growth by enhancing accessibility and convenience in the diagnosis and treatment of sleep disorders.

Restraints in the Global Sleep Disorder Market

Despite the growing awareness, there is still a lingering stigma surrounding sleep disorders, which causes some individuals to refrain from seeking professional help. Furthermore, in certain regions, a lack of awareness poses a barrier to early diagnosis and treatment.

In specific areas, health insurance may not cover sleep disorder treatments and diagnostics, acting as a deterrent for individuals seeking proper care due to financial concerns.

Market Trends of the Global Sleep Disorder Market

The utilization of telemedicine and remote monitoring solutions has experienced a significant increase, allowing individuals to receive diagnosis and treatment for sleep disorders from their residences. This surge has been propelled by the COVID-19 pandemic, prompting the emergence of virtual sleep clinics and wearable technologies for remote sleep tracking.

Another notable trend is the incorporation of artificial intelligence (AI) and machine learning (ML) into Computer-Aided Engineering (CAE) software. These technologies enhance the accuracy of simulations, facilitate quicker optimization, and automate repetitive tasks, thereby improving the efficiency and precision of engineering analyses.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Sleep Disorder Market by Type of Sleep Disorder

Market Overview
Insomnia
Sleep Apnea
Restless Legs Syndrome (RLS)
Narcolepsy
Parasomnias (sleepwalking
night terrors
etc.)
and Circadian Rhythm Disorders.

Global Sleep Disorder Market by Diagnosis Method

Market Overview
Polysomnography (PSG)
Actigraphy
Home Sleep Apnea Test (HSAT)
Multiple Sleep Latency Test (MSLT)
Electroencephalography (EEG)
and Others

Global Sleep Disorder Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

ResMed Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fisher & Paykel Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inspire Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sleep Number Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips NV.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natus Medical Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Compumedics Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Itamar Medical Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DeVilbiss Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Drive DeVilbiss Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NovaSom, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Brain Monitoring
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SleepMed Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sefam
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BMC Medical Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments